Together, these findings established that nPAK4 is a potent endogenous repressor of the ERα transactivation function and that nPAK4 may repress the expression of the ERα-induced gene LIFR in breast cancer cells, leading to bone metastasis. Here, ESR1 is linked to breast cancer.